Le Lézard
Classified in: Health
Subjects: PDT, PLW

Xoran Announces New Patent for Modular Computed Tomography System Assembly


ANN ARBOR, Mich., June 8, 2022 /PRNewswire/ -- Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly.

"... this advancement means that ultra-compact CT can fit into existing ambulances for early stroke detection ... " 

"This revolutionary cone beam CT configuration paired with our twenty-and-counting current patents unlocks new capabilities. The technology is just the beginning of a new generation of Xoran's point-of-care (POC) imaging devices," explains Misha Rakic, Xoran CEO. "In the future, this advancement means that ultra-compact CT can fit into existing ambulances for early stroke detection without the need for a dedicated mobile stroke unit. It can be used by first responders in front-line and natural disaster scenarios as well as by military on the battlefield. The possibilities for highly deployable head CT are virtually limitless."

Over 795,000 individuals suffer from strokes each year in the U.S. alone. When an individual is suffering from acute stroke, time is of the essence; however, it is critically important to assess the type of stroke as well as the amount and location of potentially recoverable brain tissue to determine the appropriate treatment routing and priority to achieve the best outcome for that individual.

Xoran Technologies has patented and prototyped a novel, highly compact cranial CT device, which could in the future enable cerebral perfusion studies to be performed in a wider range of clinical settings, to service more patients?rapidly and at the POC after the onset of stroke symptoms.

About Xoran Technologies

Since 2001, Xoran has been the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care. Providers around the world rely on our industry-leading MiniCATtm, xCATtm, and veterinary CT systems: VetCAT and vTRON, to diagnose and treat patients.

Xoran is based in Ann Arbor, Michigan.

For more information visit www.xorantech.com

© 2022 Xoran Technologies, LLC

SOURCE Xoran Technologies, LLC


These press releases may also interest you

at 19:35
CV Sciences, Inc.  (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated...

at 19:32
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that the first patients with diabetic retinopathy...

at 19:21
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced that the Center for Drug...

at 18:30
Cannabix Technologies Inc. (the "Company or Cannabix") reports that it has entered into an arm's length marketing agreements with the following parties: Effective May 13, 2024, the Company has engaged Financial Buzz Media Networks LLC ("FBMN") for...

at 18:25
It is with great pleasure that we announce the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks...

at 18:03
Kelyniam Global , a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024.  Financial highlights for the three months ended March 31, 2024 and the same period in 2023 include:  Total revenue of $957,447...



News published on and distributed by: